Ban Y, Wang M C, Chu T M
Urol Clin North Am. 1984 May;11(2):269-76.
The authors review recent developments in the immunodiagnosis of prostatic cancer. Monoclonal antibodies to prostatic acid phosphatase, prostate-specific antigen, and several human prostate and prostate-cancer-related components are available. Prostatic acid phosphatase and prostatic antigen assays are still the only immunologic tools with clinical applications.
作者们回顾了前列腺癌免疫诊断方面的最新进展。现已获得针对前列腺酸性磷酸酶、前列腺特异性抗原以及几种人类前列腺和前列腺癌相关成分的单克隆抗体。前列腺酸性磷酸酶和前列腺抗原检测仍然是仅有的具有临床应用价值的免疫学工具。
